Sporadic early-onset colorectal cancer is a specific sub-type of cancer: A morphological, molecular and genetics study

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Kirzin, Sylvain ^a,b   Marisa, Laetitia ^c   Guimbaud, Rosine ^a,b   De Reynies, Aurélien ^c   Legrain, Michèle ^d   Laurent Puig, Pierre ^e   Cordelier, Pierre ^a   Pradère, Bernard ^b   Bonnet, Delphine ^b   Meggetto, Fabienne ^a   Portier, Guillaume ^b   Brousset, Pierre ^a,b   Selves, Janick ^a,b  

^a CANCER RESEARCH CENTER OF TOULOUSE   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c Cartes d'Identité des Tumeurs Program Ligue Nationale Contre le Cancer   (France)

^d HÔPITAL DE HAUTEPIERRE   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; BETA CATENIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P53; SCATTER FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; WNT PROTEIN; TRANSCRIPTOME;

ADULT; ARTICLE; BRAF GENE; CANCER CLASSIFICATION; COLORECTAL CANCER; FAMILY HISTORY; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROSATELLITE INSTABILITY; MOLECULAR GENETICS; ONCOGENE K RAS; ONSET AGE; PHENOTYPE; PIK3CA GENE; SIGNAL TRANSDUCTION; TP53 GENE; AGED; CANCER GRADING; CANCER STAGING; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; MIDDLE AGED; MORTALITY; MUTATION; PATHOLOGY; VERY ELDERLY;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; BETA CATENIN; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; NEOPLASM GRADING; NEOPLASM METASTASIS; NEOPLASM STAGING; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84905455346     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103159     Document Type: Article

References (49)

1. Howlader NN, Krapcho M, Neyman N, Aminou R, Altekruse SF, et al (2012) SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. http://seer.cancer.gov/csr/1975-2009pops2009/ Accessed 20August 2012
2. Siegel RL, Jemal A, Ward EM (2009) Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev 18: 1695-1698.
3. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348: 919-932. (Pubitemid 36298000)
4. Samowitz WS, Curtin K, Lin HH, Robertson MA, Schaffer D, et al. (2001) The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology 121: 830-838. (Pubitemid 32959394)
5. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, et al. (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104: 18654-18659. (Pubitemid 350210752)
6. Aaltonen LA, Peltomaki P, Mecklin JP, Jarvinen H, Jass JR, et al. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54: 1645-1648. (Pubitemid 24116162)
7. Toyota M, Issa JP (1999) CpG island methylator phenotypes in aging and cancer. Semin Cancer Biol 9: 349-357. (Pubitemid 29532861)
8. Goel A, Nagasaka T, Arnold CN, Inoue T, Hamilton C, et al. (2007) The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132: 127-138. (Pubitemid 46108731)
9. Rajagopalan H, Nowak MA, Vogelstein B, Lengauer C (2003) The significance of unstable chromosomes in colorectal cancer. Nat Rev Cancer 3: 695-701. (Pubitemid 37328824)
10. Marisa L, de Reynies A, Duval A, Selves J, Gaub MP, et al. (2013) Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med 10: e1001453.
11. Maurel J, Pottier D, Grosclaude P, Tretare B, Arveux P, et al. (1998) [Therapeutic management of colonic cancer in France]. Gastroenterol Clin Biol 22: S90-96.
12. Suraweera N, Duval A, Reperant M, Vaury C, Furlan D, et al. (2002) Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 123: 1804-1811. (Pubitemid 35408304)
13. Laurent-Puig P, Cayre A, Manceau G, Buc E, Bachet JB, et al. (2009) Analysis of PTEN, BRAF, and EGFR status in determining benefit from cetuximab therapy in wild-type KRAS metastatic colon cancer. J Clin Oncol 27: 5924-5930.
14. Weisenberger DJ, Siegmund KD, Campan M, Young J, Long TI, et al. (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38: 787-793. (Pubitemid 43980599)
15. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
16. Boyault S, Rickman DS, de Reynies A, Balabaud C, Rebouissou S, et al. (2007) Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology 45: 42-52. (Pubitemid 46144363)
17. Benjamini YH, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society Series B (Methodological) 57: 289-300.
18. Goeman JJ, Buhlmann P (2007) Analyzing gene expression data in terms of gene sets: methodological issues. Bioinformatics 23: 980-987. (Pubitemid 47050585)
19. Dinu I, Potter JD, Mueller T, Liu Q, Adewale AJ, et al. (2007) Improving gene set analysis of microarray data by SAM-GS. BMC Bioinformatics 8: 242.
20. Jass JR, Biden KG, Cummings MC, Simms LA, Walsh M, et al. (1999) Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. J Clin Pathol 52: 455-460. (Pubitemid 29281765)
21. INCA (2011) La polypose associée aux mutations bi-alléliques du gène MUTYH.http://www.e-cancet.fr
22. Fairley TL, Cardinez CJ, Martin J, Alley L, Friedman C, et al. (2006) Colorectal cancer in U.S. adults younger than 50 years of age, 1998-2001. Cancer 107: 1153-1161. (Pubitemid 44384821)
23. Antelo M, Balaguer F, Shia J, Shen Y, Hur K, et al. (2012) A high degree of LINE-1 hypomethylation is a unique feature of early-onset colorectal cancer. PLoS One 7: e45357.
24. Perea J, Alvaro E, Rodriguez Y, Gravalos C, Sanchez-Tome E, et al. (2010) Approach to early-onset colorectal cancer: clinicopathological, familial, molecular and immunohistochemical characteristics. World J Gastroenterol 16: 3697-3703.
25. Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, et al. (2012) Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. PLoS One 7: e38175.
26. Parramore JB, Wei JP, Yeh KA (1998) Colorectal cancer in patients under forty: presentation and outcome. Am Surg 64: 563-567; discussion 567-568.
27. Chiang JM, Chen MC, Changchien CR, Chen JS, Tang R, et al. (2003) Favorable influence of age on tumor characteristics of sporadic colorectal adenocarcinoma: patients 30 years of age or younger may be a distinct patient group. Dis Colon Rectum 46: 904-910. (Pubitemid 36875486)
28. Liang JT, Huang KC, Cheng AL, Jeng YM, Wu MS, et al. (2003) Clinicopathological and molecular biological features of colorectal cancer in patients less than 40 years of age. Br J Surg 90: 205-214. (Pubitemid 36237896)
29. Hill DA, Furman WL, Billups CA, Riedley SE, Cain AM, et al. (2007) Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 25: 5808-5814.
30. Chang DT, Pai RK, Rybicki LA, Dimaio MA, Limaye M, et al. (2012) Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features. Mod Pathol 25: 1128-1139.
31. Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, et al. (2009) Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 33: 572-582.
32. Heimann TM, Oh C, Aufses AH, Jr. (1989) Clinical significance of rectal cancer in young patients. Dis Colon Rectum 32: 473-476. (Pubitemid 19148675)
33. Varma JR, Sample L (1990) Colorectal cancer in patients aged less than 40 years. J Am Board Fam Pract 3: 54-59.
34. O'Connell JB, Maggard MA, Liu JH, Etzioni DA, Ko CY (2004) Are survival rates different for young and older patients with rectal cancer? Dis Colon Rectum 47: 2064-2069. (Pubitemid 40179066)
35. Mitry E, Benhamiche AM, Jouve JL, Clinard F, Finn-Faivre C, et al. (2001) Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum 44: 380-387. (Pubitemid 32226327)
36. Jass JR (2007) Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130.
37. Berg M, Danielsen SA, Ahlquist T, Merok MA, Agesen TH, et al. (2010) DNA sequence profiles of the colorectal cancer critical gene set KRAS-BRAF-PIK3CA-PTEN-TP53 related to age at disease onset. PLoS One 5: e13978.
38. Goel A, Xicola RM, Nguyen TP, Doyle BJ, Sohn VR, et al. (2010) Aberrant DNA methylation in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology 138: 1854-1862.
39. Alsop K, Mead L, Smith LD, Royce SG, Tesoriero AA, et al. (2006) Low somatic K-ras mutation frequency in colorectal cancer diagnosed under the age of 45 years. Eur J Cancer 42: 1357-1361. (Pubitemid 43903168)
40. Kumar K, Brim H, Giardiello F, Smoot DT, Nouraie M, et al. (2009) Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans. Clin Cancer Res 15: 1155-1161.
41. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, et al. (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91: 355-358. (Pubitemid 39037083)
42. Kim H, Nam SW, Rhee H, Shan Li L, Ju Kang H, et al. (2004) Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas. Oncogene 23: 6218-6225. (Pubitemid 39215292)
43. Glaab E, Baudot A, Krasnogor N, Valencia A (2010) Extending pathways and processes using molecular interaction networks to analyse cancer genome data. BMC Bioinformatics 11: 597.
44. Laurent-Puig P, Manceau G, Zucman-Rossi J, Blons H (2012) Dual blockade of epidermal growth factor receptor-induced pathways: a new avenue to treat metastatic colorectal cancer. J Clin Oncol 30: 1550-1552.
45. Onizawa M, Nagaishi T, Kanai T, Nagano K, Oshima S, et al. (2009) Signaling pathway via TNF-alpha/NF-kappaB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis. Am J Physiol Gastrointest Liver Physiol 296: G850-859.
46. Agesen TH, Berg M, Clancy T, Thiis-Evensen E, Cekaite L, et al. (2011) CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer. Genes Immun 12: 653-662.
47. Popivanova BK, Kitamura K, Wu Y, Kondo T, Kagaya T, et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 118: 560-570. (Pubitemid 351206546)
48. Hong Y, Ho KS, Eu KW, Cheah PY (2007) A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res 13: 1107-1114. (Pubitemid 46424049)
49. Nam S, Park T (2012) Pathway-based evaluation in early onset colorectal cancer suggests focal adhesion and immunosuppression along with epithelial-mesenchymal transition. PLoS One 7: e31685.